MKP1 Regulates the Induction of MUC5AC Mucin by Streptococcus pneumoniae Pneumolysin by Inhibiting the PAK4-JNK Signaling Pathway

Mucosal epithelial cells in the respiratory tract act as the first line of host innate defense against inhaled microbes by producing a range of molecules for clearance. In particular, epithelial mucins facilitate the mucociliary clearance by physically trapping the inhaled microbes. Up-regulation of...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of biological chemistry Vol. 283; no. 45; pp. 30624 - 30631
Main Authors Ha, Un-Hwan, Lim, Jae Hyang, Kim, Hyun-Joong, Wu, Weihui, Jin, Shouguang, Xu, Haidong, Li, Jian-Dong
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 07.11.2008
American Society for Biochemistry and Molecular Biology
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Mucosal epithelial cells in the respiratory tract act as the first line of host innate defense against inhaled microbes by producing a range of molecules for clearance. In particular, epithelial mucins facilitate the mucociliary clearance by physically trapping the inhaled microbes. Up-regulation of mucin production thus represents an important host innate defense response against invading microbes. Excess mucin production, however, overwhelms the mucociliary clearance, resulting in defective mucosal defenses. Thus, tight regulation of mucin production is critical for maintaining an appropriate balance between beneficial and detrimental outcomes. Among various mechanisms, negative regulation plays an important role in tightly regulating mucin production. Here we show that the PAK4-JNK signaling pathway acted as a negative regulator for Streptococcus pneumoniae pneumolysin-induced MUC5AC mucin transcription. Moreover pneumolysin also selectively induced expression of MKP1 via a TLR4-dependent MyD88-TRAF6-ERK signaling pathway, which inhibited the PAK4-JNK signaling pathway, thereby leading to up-regulation of MUC5AC mucin production to maintain effective mucosal protection against S. pneumoniae infection. These studies provide novel insights into the molecular mechanisms underlying the tight regulation of mucin overproduction in the pathogenesis of airway infectious diseases and may lead to development of new therapeutic strategies.
Bibliography:To whom correspondence should be addressed: Dept. of Microbiology and Immunology, Box 672, University of Rochester Medical Center, 601 Elmwood Ave., Rochester, NY 14642. Tel.: 585-275-7195; Fax: 585-276-2231; E-mail; Jian-Dong_Li@urmc.rochester.edu.
This work was supported, in whole or in part, by National Institutes of Health Grants DC004562 and DC005843 (to J.-D. L.) and Training Grant DC008703 (to U.-H. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Present address: Dept. of Biotechnology and Bioinformatics, College of Science and Technology, Korea University, Korea, Chungnam 399-700.
ISSN:0021-9258
1083-351X
DOI:10.1074/jbc.M802519200